000			02029 a2200565 4500
005			20250514031906.0
264		0	_c20020510
008			200205s 0 0 eng d
022			_a1524-4539
024	7		_a10.1161/01.cir.0000014618.91633.67 _2doi
040			_aNLM _beng _cNLM
100	1		_aWassmann, Sven
245	0	0	_aRaloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. _h[electronic resource]
260			_bCirculation _cApr 2002
300			_a2083-91 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntihypertensive Agents _xpharmacology
650	0	4	_aAorta _xdrug effects
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aCulture Techniques
650	0	4	_aEndothelium, Vascular _xdrug effects
650	0	4	_aHypertension _xmetabolism
650	0	4	_aMale
650	0	4	_aMuscle, Smooth, Vascular _xmetabolism
650	0	4	_aNADPH Oxidases _xmetabolism
650	0	4	_aNitric Oxide _xbiosynthesis
650	0	4	_aNitric Oxide Synthase _xmetabolism
650	0	4	_aNitric Oxide Synthase Type III
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aRaloxifene Hydrochloride _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Inbred SHR
650	0	4	_aRats, Wistar
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aSelective Estrogen Receptor Modulators _xpharmacology
650	0	4	_aVasoconstriction _xdrug effects
650	0	4	_aVasodilation _xdrug effects
700	1		_aLaufs, Ulrich
700	1		_aStamenkovic, Djordje
700	1		_aLinz, Wolfgang
700	1		_aStasch, Johannes-Peter
700	1		_aAhlbory, Katja
700	1		_aRösen, Renate
700	1		_aBöhm, Michael
700	1		_aNickenig, Georg
773	0		_tCirculation _gvol. 105 _gno. 17 _gp. 2083-91
856	4	0	_uhttps://doi.org/10.1161/01.cir.0000014618.91633.67 _zAvailable from publisher's website
999			_c11881102 _d11881102